Mark W. Frohlich

Insider Reports History

Location
Seattle, WA
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark W. Frohlich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 1.25K $23.8K $19.06 23 May 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 1.5K 23 May 2025 Direct

Insider Reports Filed by Mark W. Frohlich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RIGL RIGEL PHARMACEUTICALS INC 23 May 2025 2 $0 4 Director 28 May 2025, 17:26
RIGL RIGEL PHARMACEUTICALS INC 06 Mar 2025 1 $0 4 Director 10 Mar 2025, 17:42
RIGL RIGEL PHARMACEUTICALS INC 06 Mar 2025 0 $0 3 Director 10 Mar 2025, 17:41